Sgpharma Global Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.76 M
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 603.48%
- Profit Growth -3457.61%
- Net Worth -45.78%
- Total Assets 1376.83%
About Sgpharma Global
Sgpharma Global Private Limited (SGPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 November 2020 (Four years and three months 10 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.76 M, as per Ministry of Corporate Affairs (MCA) records.
Chetan Bhagat and Bhavesh Bhagat serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24290MH2020PTC350222
- Company No.
350222
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Nov 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Pharma
Who are the key members and board of directors at Sgpharma Global?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chetan Bhagat  | Director | 17-Nov-2020 | Current |
| Bhavesh Bhagat | Director | 17-Nov-2020 | Current |
Financial Performance of Sgpharma Global.
Sgpharma Global Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 603.48% increase. The company also saw a substantial fall in profitability, with a 3457.61% decrease in profit. The company's net worth observed a substantial decline by a decrease of 45.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Sgpharma Global?
Unlock access to Sgpharma Global's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Sgpharma Private Limited
Chetan Bhagat and Bhavesh Bhagat are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sgpharma Global?
Sgpharma Global has a workforce of 0 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sgpharma Global, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sgpharma Global's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.